BioGraph 55

Developer of novel B-cell therapies and drugs designed to address significant unmet clinical needs of autoimmunity. The company offers discovering and developing bispecific antibodies for immuno-oncol...

Healthcare

San Francisco, CA, United States

Founded 2014

4 employees

Website

Valuation

$25M

Market implied

Share Price

N/A

Total Raised

$20.1M

Last Round

N/A

Investors

+6 other investors

View all 6 investors

Valuation History

0 funding rounds on record

Cap Table

Ownership structure

Market Activity

Secondary transactions

Get the full picture

Create a free account to unlock BioGraph 55's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required